Jump to Navigation

Facebook Connect

User login

nla






Overview


Join the National Lipid Association in New Orleans for the 2016 Scientific Sessions, May 19-22, 2016 at the New Orleans Hyatt Regency.

Call for Abstracts
The 2016 NLA Abstract Committee invites the submission of abstracts to be presented at the 2016 NLA Scientific Sessions in New Orleans from May 19-22, 2016. Submitted abstracts will be considered for the poster hall and oral presentation during the abstract session at the meeting. All accepted abstracts will be published in the Scientific Sessions edition of the Journal of Clinical Lipidology and will be posted on the 2016 NLA poster hall website. Click here for more information.

Agenda


Thursday, May 19, 2016

Session I
3:45- 4:00 PM
NLA Presidents Welcome
Carl E. Orringer, MD, FNLA
4:00- 4:30 PM
Human genetics and CV Risk Assessment
Nathan O. Stitziel, MD, PhD
4:30- 5:00 PM
Human Genetics Impact on Clinical Practice in Lipidology
Muredach P. Reilly, MBBCH
5:00- 5:30 PM
Gene Therapy
Marina Cuchel, MD, PhD
5:30- 6:00 PM
ARS Questions/ Panel Session Q&A
6:00- 7:00 PM
Welcome Reception in Exhibit Hall
7:00- 9:00 PM
CME Dinner Symposium

Friday, May 20, 2016

6:30- 8:00 AM
CME Breakfast Symposium
8:00- 8:15 AM
Chapter Business Meetings
8:15- 8:25 AM
Morning Notes and ARS Questions
8:25- 9:25 AM
Keynote Lecture: Apo C3 , Risk factor, Pathophysiology and Target
Anne Tybjærg-Hansen, MD, DMSc
9:25- 10:25 AM
Break in Exhibit Hall & Poster Hall Q&A Session
Session II
10:25- 10:30 AM
ARS Questions
10:30- 10:55 AM
Epidemiology of Lipoprotein(a)
Børge G. Nordestgaard, MD, DMSc
10:55- 11:20 AM
Pathophysiology of Lipoprotein(a)- Atherosclerosis & Thrombosis
Sergio Fazio, MD, PhD
11:20- 11:45 AM
Drugs in Development to Treat Lp(a): Risk Reduction vs. Lowering a number - What can we expect?
Christie M. Ballantyne, MD, FNLA
11:45- 12:05 PM
ARS Questions/ Panel Session Q&A
12:05- 12:15 PM
Young Investigator Awards & Chapter Business Meeting
12:15- 1:15 PM
Lunch in Exhibit Hall
Clinical Track
1:15- 1:20 PM
ARS Questions
1:20- 1:30 PM
Oral Poster Presentation
1:30- 2:00 PM
Inherited TG disorders
Anne C. Goldberg, MD, FNLA
2:00- 2:10 PM
Oral Poster Presentation
2:10- 2:40 PM
Uncommon Dyslipidemias with Common Presentations
James A. Underberg, MD, MS, FNLA
2:40- 3:10 PM
Break in Exhibit Hall
3:10- 3:20 PM
Oral Poster Presentation
3:20- 3:50 PM
Lipid Lowering Drug Interactions : What you really need to know
Barbara S. Wiggins, PharmD, CLS, FNLA
3:50- 4:20 PM
ARS Questions/ Panel Session Q&A
Basic Science Track
1:15- 1:20 PM
ARS Questions
1:20- 1:30 PM
Oral Poster Presentation
1:30- 2:00
LDL Receptor Biology
Allan D. Sniderman, MD
2:00- 2:10 PM
Oral Poster Presentation (Hunninghake Award)
2:10- 2:40 PM
New Insights into Omega-3 Fatty Acids and Lipids using Nanotechnology Approaches
R. Preston Mason, MD, MBA
2:40- 3:10 PM
Break in Exhibit Hall
3:10- 3:40 PM
HDL Biology New Research
3:40- 4:10 PM
The Role of Hepatic Endothelial Lipase in the Catabolism of VLDL
W. Virgil Brown, MD, FNLA
4:10- 4:30 PM
ARS Questions/ Panel Session Q&A
7:30- 9:30 PM
CME Dinner Symposium

Saturday, May 21, 2016

6:30- 8:00 AM
CME Breakfast Symposium
8:00- 8:15 AM
Chapter Business Meetings
8:15- 8:25 AM
Morning Notes and ARS Questions
8:25- 9:25 AM
Non-alcoholic Fatty Liver Disease
David Cohen, MD
9:25- 10:00 AM
Break in Exhibit Hall & Poster Hall Q&A Session
10:00- 10:10 AM
Chapter Business Meeting
Session III
10:10- 10:20 AM
ARS Questions
10:20- 10:45 AM
2016 Update on Investigational Lipid Pharmacotherapies
Harold E. Bays, MD, FNLA
10:45- 11:10 AM
Update on PCSK9- Science Matters
Erik Stroes, MD, PhD
11:10- 11:35 AM
Coronary Artery Calcium Scoring in Young and Low Risk Patients: Impact on lipid lowering pharmacotherapy choices
Michael J. Blaha, MD, MPH
11:35- 11:55 AM
ARS Questions/ Panel Session Q&A
11:55- 12:20 PM
NLA & Foundation News & Notes
12:20- 1:20 PM
Lunch in Exhibit Hall
Session IV
1:20- 1:30 PM
ARS Questions
1:30- 1:55 PM
Canadian Perspective of Pediatric Lipid Disorders
Julie St-Pierre, MD, PhD
1:55- 2:20 PM
Updates to the 2016 NLA Annual Summary
Harold E. Bays, MD, FNLA
2:20- 2:45 PM
ACC Expert Consensus Panel Recommendations on Non-Statin therapy to Reduce ASCVD Risk
Carl E. Orringer, MD, FNLA
2:45- 3:10 PM
ARS Questions/ Panel Session Q&A
Session V
3:10- 3:20 PM
ARS Questions
3:20- 3:45 PM
HoFH / European Perspective
Marina Cuchel, MD, PhD
3:45- 4:10 PM
USA Cascade FH one year data/FindFH /New Recommendations
Joshua W. Knowles, MD, PhD
4:10- 4:35 PM
Does Genetic Testing in FH Impact Clinical Care? Pros and Cons
Jacques Genest, MD
4:35- 5:00 PM
ARS Questions/ Panel Session Q&A
6:00- 7:00 PM
Honors and Awards Ceremony
8:00- 10:00 PM
Foundation of the National Lipid Association Event

Sunday, May 22, 2016

8:00- 8:45 AM
Continental Breakfast
8:45- 9:00 AM
Morning Notes & ARS Questions
9:00- 10:00 AM
Keynote Lecture: Smartphone Applications for Patients' Health and Fitness
John P. Higgins, MD, MBA, MPhil
Session VI: Breakout 1- HIV/AIDS , Dyslipidemia and ASCVD
10:00- 10:05
Activity Overview
10:05- 10:30 AM
Overview of HIV and CVD: The Future is Here!
Judith Aberg, MD
10:30- 10:55 AM
Risk Stratification for ASCVD in the Patient Living with HIV
Merle Myerson, MD, FNLA
10:55- 11:20 AM
Residual Risk in the Patient with HIV
11:20- 11:45 AM
The Complex Patient: HIV Plus a Whole Lot Else
Chris T. Longenecker, MD
11:45- 12:00 PM
Panel Session Q&A
Session VI: Breakout 2- Women's Health- Menopause, PCOS, & Pregnancy
10:00- 10:05 AM
Session Overview
10:05- 10:30 AM
ASCVD Risk Assessment in Pre- and Post-menopausal Women: Is it all about age?
Martha Gulati, MD, MS
10:30- 10:55 AM
Lipid Management in Pregnancy and FH: An Oxymoron or an Art?
Pamela B. Morris, MD, FNLA
10:55- 11:20 AM
Selecting the Right Contraception for the Dyslipidemic Woman
Robert A. Wild, MD, MPH, PhD, FNLA
11:20- 11:45 AM
Counseling the Dyslipidemia Post-Menopausal Woman on the Lipid Effects of HRT
Gina Lundberg, MD
11:45- 12:00 PM
Panel Session Q&A
Session VI: Breakout 3- Nutrition and Lifestyle Interventions
10:00- 10:05 AM
Activity Overview
10:05- 10:30 AM
The Obesity Epidemic
Joyce L Ross, MSN, CRNP, CLS, FNLA
10:30- 10:55 AM
Current Nutrition Guidelines/NLA Recommendations
Lori Alexander, MSHS, RD, CLS, FNLA
10:55- 11:20 AM
Understanding the Role of Physical Activity
Ralph LaForge, MSc, CLS, FNLA
11:20- 11:45 AM
Implementing Behavioral Change
11:45- 12:00 PM
Panel Session Q&A

The NLA invites speakers and guests to provide scientific medical opinion, which do not necessarily reflect the policy of the NLA. The schedule and faculty are subject to change.

Faculty


Featured Sessions


Coming Soon

This information is still being developed by our program developers. Please check back soon for updates to be posted as soon as they are available. Also, check for updates in your email. If you are not currently on our emal blast list and you would like to receive communications from and information about NLA programs, Click Here to sign up.

Accreditation


Target Audience

This activity is designed to meet the needs of physicians, physician assistants, pharmacists, registered nurses, nurse practitioners, advance practice registered nurses and registered dietitians with an interest in lipid management.

Type of Activity
Live Activity
Knowledge
Application

Educational Objectives
At the conclusion of this activity, registered nurses and nurse practitioners should be able to provide appropriate counsel for patients and their families.

At the conclusion of this activity, all participants should be able to:

Session I: The Impact of Genetics in Lipidology?

  • Apply insight from human population genetics studies to identify novel therapeutic targets for a better understanding for atherosclerotic cardiovascular disease.
  • Describe the current and future technologies available for genetic screen including  how to apply them in clinical practice both for diagnosis and risk assessment
  • Discuss experimental techniques in development for genetic manipulation to target inherited lipid disorders

Keynote I

  • Discuss ApoC3 as both a risk factor for ASCVD and as potential for therapeutic manipulation

Session II: Focus on Lipoprotein(a)

  • Discuss the epidemiology of Lipoprotein(a) (LP(a)) for both thrombosis and ASCVD
  • Discuss the pathophysiology of LP(a) and how this impacts increased risk of ASCVD and thrombosis
  • Discuss the status of current and emerging treatment options targeting LP(a)

Clinical Lipidology Track

  • Critically appraise emerging research and its applications to daily clinical practice
  • Discuss the diagnosis and treatment of genetic hypertriglyceridemia
  • Describe the  approach to diagnosis and therapeutic interventions available to manage uncommon dyslipidemias with common clinical presentations
  • Discuss the clinically relevant drug and non-drug interactions of lipid lowering drugs

Research Track

  • Critically appraise emerging research and its applications to daily clinical practice
  • Describe current and emerging research in the field of LDL receptor biology
  • Discuss new and emerging treatment for triglyceride biology
  • Discuss new and emerging treatment for HDL biology
  • Discuss evidence regarding hepatic lipase and its impact on ApoC3 and lipoprotein biology

Keynote II

  • Discuss novel concepts in fatty liver disease

Session III- Updates in Lipid Therapeutics

  •  Describe the efficacy, safety, and mechanisms of action of novel lipid-targeted pharmacotherapies
  • Examine the data on safety and efficacy of therapies that target proprotein convertase subtilisin/kexin type 9 (PCSK9)
  • Discuss the clinical application of coronary calcium scores

Session IV- Updates in Lipid Recommendations

  • Discuss Canadian lipid screening and other strategies in children in reducing cardiovascular risk
  • Demonstrate the practical application of the NLA Annual Summary to the clinical evaluation and management of patients with dyslipidemia
  • Discuss current guidelines & recommendations on the diagnosis, management, & treatment of dyslipidemia

Session V- Familial Hypercholesterolemia (FH)- Where do we go from here?

  • Outline European guidelines and recommendations for managing Patients with HoFH
  • Illustrate the importance of universal screening during childhood and cascade lipid screening of family members of known FH patients.
  • Discuss the importance of genetic testing and clinical care for a patient with FH.

Keynote III

  • Discuss the potential role of applications in optimizing lipid management

Session VI- HIV/ AIDS

  • Discuss atherosclerosis in patients with HIV.
  • Differentiate the factors that lead to residual risk in the patient with HIV
  • Apply lipid-lowering treatment strategies in patients with HIV

Session VI- Women’s Health

  • Compare and contrast available risk assessment algorithms (including FRS, ACC/AHA CV Risk Calculator, Reynolds Risk Score, new MESA algorithm) and their accuracy (over- and underestimation) in women
  • Appraise treatment recommendations and evidence for screening, diagnosing and treating FH during pregnancy
  • Describe the impacts of various forms of oral contraception on lipid levels in various types of dyslipidemia.
  • Implement appropriate dyslipidemia management during menopause transition

Session VI- Nutrition & Lifestyle

  • Describe the current guidelines on the diagnosis, management and treatment of obesity
  • Discuss current guidelines & recommendations for nutrition & lifestyle interventions in various populations
  • Review the role of various types of physical activity on dyslipidemia and cardiovascular risk
  • Implement strategies that  improve patient adherence and compliance

 

CME credit provided by the National Lipid Association

Physicians
The National Lipid Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The National Lipid Association designates this live activity for a maximum of 18 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in this activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 18 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL002.


CE credit provided by Postgraduate Institute for Medicine

Pharmacists
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Session I- Universal Activity Number 0809-9999-16-130-L01-P (Application)
Postgraduate Institute for Medicine designates this continuing education activity for 2.25 contact hour(s) (.225 CEUs) of the Accreditation Council for Pharmacy Education

Keynote I- Universal Activity Number 0809-9999-16-131-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (.10 CEUs) of the Accreditation Council for Pharmacy Education

Session II – Universal Activity Number 0809-9999-16-132-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 1.75 contact hour(s) (.175 CEUs) of the Accreditation Council for Pharmacy Education

Clinical Breakout– Universal Activity Number 0809-9999-16-133-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 2.50 contact hour(s) (.250 CEUs) of the Accreditation Council for Pharmacy Education

Research Breakout – Universal Activity Number 0809-9999-16-016-134-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 2.75 contact hour(s) (.275 CEUs) of the Accreditation Council for Pharmacy Education

Keynote II – Universal Activity Number 0809-9999-16-135-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (.10 CEUs) of the Accreditation Council for Pharmacy Education

Session III – Universal Activity Number 0809-9999-16-136-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hour(s) (.20 CEUs) of the Accreditation Council for Pharmacy Education

Session IV – Universal Activity Number 0809-9999-16-137-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 1.75 contact hour(s) (.175 CEUs) of the Accreditation Council for Pharmacy Education

Session V – Universal Activity Number 0809-9999-16-138-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 1.75 contact hour(s) (.175 CEUs) of the Accreditation Council for Pharmacy Education

Keynote III – Universal Activity Number 0809-9999-16-139-L01-P (Knowledge)
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (.10 CEUs) of the Accreditation Council for Pharmacy Education

Session VI HIV/AIDS – Universal Activity Number 0809-9999-16-140-L01-P (Application)
Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hour(s) (.20 CEUs) of the Accreditation Council for Pharmacy Education

Session VI Women’s Health – Universal Activity Number 0809-9999-16-141-L01-P (Application)
Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hour(s) (.20 CEUs) of the Accreditation Council for Pharmacy Education

Session VI Nutrition & Lifestyle – Universal Activity Number 0809-9999-16-142-L01-P (Application)
Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hour(s) (.20 CEUs) of the Accreditation Council for Pharmacy Education

Nursing
This educational activity for 17.2 contact hours is provided by the Postgraduate Institute for Medicine.
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Session I- 2.4 credits; Keynote I- 1.0 credits; Session II- 1.6 credits; Clinical Breakout- 2.5 credits; Research Breakout- 2.7 credits; Keynote II- 1.0 credits; Session III- 1.9 credits; Session IV- 1.8 credits; Session V- 1.8 credits; Keynote III- 1.0 credits; Session VI HIV/AIDS- 2.0 credits; Session VI Women’s Health- 2.0 credits; Session XII Nutrition & Lifestyle- 2.0 credits.  

Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

Pre-Conference Courses


The NLA’s Masters in Lipidology Course is an intensive 2-day training course offers an in-depth review of the core curriculum in Clinical Lipidology for health care professionals who desire to practice at an advanced level within the field. Learn from leading experts, assess your knowledge of lipid science and advance your personal standard of practice.
 

The NLA's Lipid Academy provides a comprehensive, in-depth indoctrination to lipid science and is open to all health care professionals interested in developing a core competency in the diagnosis and treatment of dyslipidemia. The interactive Lipid Academy course provides health professionals with the knowledge and tools necessary to work effectively in a lipid practice, and will serve as a preparatory course for the Annual Scientific Forum and other advanced lipid training.
 

The National Lipid Association (NLA) coding course Advances in Coding and Business Development Strategies for Lipid and Cardiometabolic Risk Reduction Programs has been designed to assist in assuring accurate coding and reimbursement by offering a variety of educational programs and coding tools for NLA members including physicians, nurses, pharmacists, coders, technicians and administrators with a basic understanding of CPT and ICD-9.

Abstracts


Call for Abstracts
The 2016 NLA Abstract Committee invites the submission of abstracts to be presented at the 2016 NLA Scientific Sessions in New Orleans from May 19-22, 2016. Submitted abstracts will be considered for the poster hall and oral presentation during the abstract session at the meeting. All accepted abstracts will be published in the Scientific Sessions edition of the Journal of Clinical Lipidology and will be posted on the 2016 NLA poster hall website. Click here for more information.

Foundation Event


Foundation Event Coming Soon

This information is still being developed by our program developers. Please check back soon for updates to be posted as soon as they are available. Also, check for updates in your email. If you are not currently on our emal blast list and you would like to receive communications from and information about NLA programs, Click Here to sign up.

CME Symposia


Interested in hosting a CME Symposia in conjunction with the NLA’ Spring Clinical Lipid Update in San Diego? Please contact Lindsay Hart lhart@lipid.org for more information. Availability is limited. 

Expert Theatre


Interested in hosting an Expert Theatre in conjunction with the NLA’ Spring Clinical Lipid Update in San Diego? Please contact Leia Hutfles lhutfles@lipid.org for more information. Availability is limited. 

Honors and Awards Ceremony


Honors and Awards Ceremony Coming Soon

This information is still being developed by our program developers. Please check back soon for updates to be posted as soon as they are available. Also, check for updates in your email. If you are not currently on our emal blast list and you would like to receive communications from and information about NLA programs, Click Here to sign up.

Mentor and Mentee Reception


Mentors and Mentees Coming Soon

This information is still being developed by our program developers. Please check back soon for updates to be posted as soon as they are available. Also, check for updates in your email. If you are not currently on our emal blast list and you would like to receive communications from and information about NLA programs, Click Here to sign up.

Mobile App


New in 2016! The National Lipid Association will be providing an app with onsite updates and educational content for attendees. More information coming soon about how to download the app in preparation for the meeting.

Support Recognition

Aegerion
Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases.
www.aegerion.com

Akcea Therapeutics
Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc., is focused on the development and commercialization of new treatments for patients with serious cardiometabolic lipid disorders.
www.akceatx.com

Alexion Pharmaceuticals
Description Coming Soon
alexion.com

Amarin Pharma, Inc.
Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health.  Amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids.  For more information, please visit www.amarincorp.com.


Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
www.amgen.com

Blueprint Genetics
Blueprint Genetics is a genetics company in Helsinki and San Francisco. We are a team of cardiologists, geneticists, bioinformaticians and DNA biologists providing comprehensive and high quality genetic diagnostics with Next-Generation Sequencing.
www.blueprintgenetics.com

Boston Heart Diagnostics
Boston Heart is transforming the treatment of cardiovascular disease by providing healthcare providers and their patients with novel, personalized diagnostics and reports with integrated, customized lifestyle programs.
www.bostonheartdiagnostics.com

Cardiology Today & Healio.com by SLACK Inc.
SLACK Incorporated invites you to visit our booth to pick up your free issue of CARDIOLOGY TODAY – News & Perspective for the Cardiovascular Specialist. Also see Cardiology Today’s Intervention – a practical information resource for interventional cardiologists. To receive important email updates, register at Healio.com/Cardiology.

Carlson Labratories, Inc.
Since 1965, Carlson Laboratories has produced the freshest, purest, award-winning vitamins, minerals, fish oils, and other nutritional supplements.  We continue to remain on the forefront of innovation and are proud to offer an advanced product line with over 250 innovative formulas designed with all of your nutritional needs in mind.”
www.carlsonlabs.com

Kowa Pharmaceuticals America, Inc.
Kowa Pharmaceuticals America, Inc. delivers value-based solutions to patients by investing in the advancement of cardiometabolic therapeutics. The company's flagship product is LIVALO® (pitavastatin) tablets 1mg, 2mg, 4mg.
www.livalohcp.com

LabCorp
LabCorp provides leading-edge tests and services through a national network of primary clinical and specialized laboratories to support cardiovascular disease prevention, diagnosis and management.  Services include traditional and advanced lipids; markers of inflammation, acute ischemia and heart failure; genetic tests for inherited diseases and conditions; genetic counseling and ambulatory electrocardiography.
www.QuestDiagnostics.com

Merck
Today's Merck is working to help the world be well. Through our medicines, vaccines, biologic therapies, and animal products, we work with customers and  operate in more than 140 countries to deliver innovative health solutions.  
www.merck.com

Quest Diagnostics
Quest Diagnostics, the world’s leading provider of diagnostic testing, information and services, offers the Cardio IQ Solution—a comprehensive approach to heart health.  Visit 4myheart.com and QuestDiagnostics.com.

ReachMD

ReachMD is an award-winning medical broadcasting company delivering education and information to healthcare professionals nationwide through an on air, online, and mobile distribution network.
www.reachmd.com

Sanofi-Regeneron
Sanofi, a global healthcare leader, discovers, develops, and distributes therapeutic solutions focused on patients’ needs. Regeneron, a leading biopharmaceutical company, discovers, develops, manufactures, and commercializes biologic medicines for serious medical conditions. Since 2007, Sanofi and Regeneron have collaborated to develop and commercialize fully human monoclonal antibodies utilizing proprietary technologies.
www.regeneron.com

uniQure
uniQure is delivering on the promise of gene therapy, single treatments with potentially curative results. Our lead product, Glybera, is currently the only gene therapy approved in the EU.
www.uniqure.com



 

Virtual Exhibit Hall


Virtual Exhibit Hall Coming Soon

This information is still being developed by our program developers. Please check back soon for updates to be posted as soon as they are available. Also, check for updates in your email. If you are not currently on our emal blast list and you would like to receive communications from and information about NLA programs, Click Here to sign up.

Industry Council


Industry Council coming soon...

Media Partners


 

 

 

Hyatt Regency

hotel

Hyatt Regency
601 Loyola Avenue
New Orleans, Louisiana, USA, 70113

Meeting Room Rate: $229/night++
Room Reservation Cut-Off Date: April 26, 2016

Experience the best of the Big Easy at this award-winning hotel. Hyatt Regency New Orleans is located in the heart of downtown. Enjoy spacious guestrooms and suites with city featuring stunning city views and incredible amenities including Bywater Pool, StayFit™ gym, and Le Jardin Spa. Take a ride on the Loyola Avenue Streetcar, which passes directly in front of the hotel, or take a walk to the historic French Quarter, Arts District, Audubon Aquarium of the Americas and the scenic Mississippi Riverfront – all located within one mile of the Hyatt Regency hotel.

For reservations call 1-800-633-7313 and ask for the National Lipid Association room rate.

To make your reservations online, please click here.

Local Attractions

new orleansFrench Quarter
French Quarter History consists of over 200 years of characters, chaos, and intrigue. The heart and cultural center of New Orleans is the French Quarter, a must-see for its high energy, rich history, diverse architecture, music, street performers, renowned jazz clubs, lively nightlife and the finest art galleries and restaurants in the city.

 

 

audubon zooAudubon Zoo
Located in historic Uptown New Orleans Audubon Zoo offers an exotic mix of animals from around the globe, engaging educational programs, hands-on animal encounters and lush gardens. Unique natural habitat exhibits—such as the award-winning Louisiana Swamp and Jaguar Jungle—showcase the relationship between people and nature. Audubon Zoo is often ranked among the country’s best for innovation and entertainment value!

 

 

jackson squareJackson Square
Historic Jackson Square, originally known in the 18th century as "Place d'Armes," and later renamed in honor of the Battle of New Orleans hero Andrew Jackson, is a timeless attraction in the heart of the French Quarter of New Orleans. The artists, restaurants, museums, merchants and the square itself make Jackson Square one of the French Quarter's most popular destinations.

 

 

audobon aquariumAudubon Aquarium of the Americas
Located on the Mississippi River adjacent to the French Quarter Audubon Aquarium of the Americas immerses you in an underwater world. The colors of a Caribbean reef come alive in our walk-through tunnel, while our penguins and Southern sea otter enchant you with their antics. Touch a sting ray, feed a parakeet, and marvel at our gigantic sharks, tarpon, and rays in the 400,000 gallon Gulf of Mexico Exhibit. Watch for sea turtles throughout the Aquarium—as coordinator of the Louisiana Marine Mammal and Sea Turtle Rescue Program, we prepare many of them for release to the wild.

 

new orleans museum of artNew Orleans Museum of Art
Today, the museum hosts an impressive permanent collection of almost 40,000 objects. The collection, noted for its extraordinary strengths in French and American art, photography, glass, and African and Japanese works, continues to expand and grow, making NOMA one of the top art museums in the south. The five-acre Sydney and Walda Besthoff Sculpture Garden at NOMA is one of the most important sculpture installations in the United States, with over 60 sculptures situated on a beautifully landscaped site amongst meandering footpaths, reflecting lagoons, Spanish moss-laden 200-year-old live oaks, mature pines, magnolias, camellias, and pedestrian bridges.

 

Exhibit in New Orleans



Interact with several hundred health professionals and lipid experts by supporting the 2016 NLA Scientific Sessions. Sponsorships and exhibits are designed to provide a solid platform to help you stand out and make an impact. As an exhibitor, increase your presence at this meeting by taking advantage of exhibitor-only sponsorship opportunities and showcase all your company has to offer.

We look forward to you having you join us in New Orleans.

 

Exhibit and sponsorship packages available. For more information or questions, please contact:
Leia Hutfles, Meeting Coordinator
(p) 904-309-6207 (e) lhutfles@lipid.org

Register for 2016 Scientific Sessions

Personal Information

Contact Information

Which meetings or courses would you like to attend?

Must be logged in to click NLA member price
NLA Member
Early Bird Rate

Before 4/1/16
NLA Member
Discounted Rate

After 4/1/16
Non-Member
Rate
Trainee
Rate*
Scientific Sessions**
May 19-22, 2016
$645.00
$695.00
$1150.00
$75.00
Professional Development
Masters in Lipidology Course
May 18-19, 2016
$750.00
$750.00
$1250.00
$395.00
Lipid Academy
May 18-19, 2016
$550.00
$550.00
$950.00
$0.00
NLA Coding Course
May 19, 2016
$200.00
$200.00
$200.00
$200.00
Special Events and Guest Fees
Guest Pass- Exhibit Hall
$175 x

*Non-Member Trainees must register with .PDF form.
**Includes one admission badge to Exhibit Hall for all food functions.

Total

$0.00

Payment Information

by Dr. Radut.